Filter posts

Misguided Fear of Biotech Should Not Translate to Regulatory Hurdles

A recent editorial in the New York Times lays bare how demonization of biotechnology hinders …

Maintaining a Healthy Biotech Industry

For emerging biotech companies, the economic climate remains challenging. As of April 2010, 38 percent …

BIO Media Briefing Provides Update on Key Public Policy Issues

BIO hosted a media briefing on Wednesday, June 30th, with Jim Greenwood and Rachel King, …

State of the Industry Address from 2010 BIO International Convention

This was the opening slide for my talk in Atlanta last year. We found ourselves …

A Disin‘gene’uous Lawsuit: ACLU Challenges DNA Patents

From the mass production of life-saving medicines in cell cultures to the screening of our …

Countering Misinformation On Biosimilars

One of the impediments to a reasonable public dialogue regarding the creation of a pathway …

Looking for Long-Term Economic Signs at BIO Partnering Meetings

In its 30-year history, biotechnology has made dramatic advances possible in health care, agriculture, energy …

Millions Around World to Observe Rare Disease Day

On Sunday, Feb. 28, millions of people around the world will observe “World Rare Disease …

Biotech Depends on Policies that Promote Innovation

The biotechnology industry’s endeavor to transform science into therapy for a previously untreatable disease is …

Welcome to BIOtech Now

BIOtech Now is the first in a number of new products from BIO intended to …